Publications by authors named "Ross Doyle"

Article Synopsis
  • Current methods for assessing disease severity and progression in Chronic Kidney Disease (CKD) are limited, prompting a study that highlights FERM-domain containing protein 3 (FRMD3) as a key candidate for further research.
  • Using RNA sequencing, the study analyzed CKD biopsies and correlated gene expression with clinical indicators, discovering 93 genes related to CKD severity and progression, including FRMD3.
  • Further investigation into FRMD3 showed its importance in cell structure and health, with knockdown experiments indicating its role in preventing cell death and maintaining cell junction integrity.
View Article and Find Full Text PDF

Introduction: Cardiovascular disease (CVD) is responsible for over 30% of mortality worldwide. CVD arises from the complex influence of molecular, clinical, social, and environmental factors. Despite the growing number of autosomal genetic variants contributing to CVD, the cause of most CVDs is still unclear.

View Article and Find Full Text PDF

Background: Chronic kidney disease (CKD) is a complex disorder that has become a high prevalence global health problem, with diabetes being its predominant pathophysiologic driver. Autosomal genetic variation only explains some of the predisposition to kidney disease. Variations in the mitochondrial genome (mtDNA) and nuclear-encoded mitochondrial genes (NEMG) are implicated in susceptibility to kidney disease and CKD progression, but they have not been thoroughly explored.

View Article and Find Full Text PDF

Increased albuminuria indicates underlying glomerular pathology and is associated with worse renal disease outcomes, especially in diabetic kidney disease. Many single nucleotide polymorphisms (SNPs), associated with albuminuria, could be potentially useful to construct polygenic risk scores (PRSs) for kidney disease. We investigated the diagnostic accuracy of SNPs, previously associated with albuminuria-related traits, on albuminuria and renal injury in the UK Biobank population, with a particular interest in diabetes.

View Article and Find Full Text PDF
Article Synopsis
  • * A study involving 1,304 individuals from the UK-Republic of Ireland and Finland found 32 specific DNA methylation sites (CpGs) associated with diabetic kidney disease in Type 1 diabetes.
  • * Of these, 21 CpGs can predict the onset of kidney failure, potentially helping identify individuals at higher risk for diabetic kidney disease.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to uncover new genetic factors linked to diabetic kidney disease (DKD) by combining data from previous genome-wide association studies (GWAS) and renal transcriptomics datasets involving nearly 27,000 diabetes patients.
  • - Researchers identified a new genetic variant (rs72831309) in the TENM2 gene that may reduce the risk of DKD, along with ten other genes associated with the disease through meta-analysis and gene-level testing.
  • - The findings indicated that certain genes exhibited altered expression patterns in kidney tissues related to DKD, suggesting their potential role in kidney health and disease management, with specific gene expressions correlating with various pathological conditions.
View Article and Find Full Text PDF

High-throughput DNA testing is becoming established as a standard diagnostic test in the renal clinic. Previously published studies on cohorts of patients with unexplained chronic kidney disease of a suspected genetic aetiology have suggested a diagnostic yield for genomic sequencing of up to 18%. Here we determine the yield of targeted gene panel in a clinically unscreened cohort of patients referred for percutaneous native renal biopsy.

View Article and Find Full Text PDF

Purpose Of Review: Nephrology lacks effective therapeutics for many of the presentations and diseases seen in clinical practice. In recent decades, we have come to understand the central place of inflammation in initiating and propagating kidney disease, and, research in more recent years has established that the resolution of inflammation is a highly regulated and active process. With this, has evolved an appreciation that this aspect of the host inflammatory response is defective in kidney disease and led to consideration of a therapeutic paradigm aiming to harness the activity of the molecular drivers of the resolution phase of inflammation.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the genetic factors that contribute to diabetic kidney disease using genome-wide association studies (GWAS) among individuals with type 1 diabetes, focusing on specific genetic variations that may increase risk for the condition.
  • Researchers analyzed genetic data from nearly 19,406 individuals and identified 16 significant genetic loci, with the strongest risk variant (rs55703767) linked to a mutation in the collagen type IV alpha 3 chain, which is important for kidney structure.
  • The findings suggest that these genetic variants, including the protective allele of rs55703767, could lead to new understanding and potential targets for preventing and treating diabetic kidney disease.
View Article and Find Full Text PDF

Objective: Vitamin D insufficiency is highly prevalent among renal transplant recipients and in observational studies is associated with adverse outcomes. Hypercalcemia, usually due to persistent hyperparathyroidism, also commonly occurs in this population and often coexists with vitamin D insufficiency. However, concern that vitamin D supplementation might exacerbate the pre-existing hypercalcemia often leads clinicians to avoid vitamin D supplementation in such patients.

View Article and Find Full Text PDF

Inflammation is an essential response to injury and its timely and adequate resolution permits tissue repair and avoidance of chronic inflammation. Ageing is associated with increased inflammation, sub-optimal resolution and these act as drivers for a number of ageing-associated pathologies. We describe the role played by specialised proresolving lipid mediators (SPMs) in the resolution of inflammation and how insufficient levels of these mediators, or compromised responsiveness may play a role in the pathogenesis of many ageing-associated pathologies, e.

View Article and Find Full Text PDF

Background And Objectives: An environmental trigger has been proposed as an inciting factor in the development of anti-GBM disease. This multicenter, observational study sought to define the national incidence of anti-GBM disease during an 11-year period (2003-2014) in Ireland, investigate clustering of cases in time and space, and assess the effect of spatial variability in incidence on outcome.

Design, Setting, Participants, & Measurements: We ascertained cases by screening immunology laboratories for instances of positivity for anti-GBM antibody and the national renal histopathology registry for biopsy-proven cases.

View Article and Find Full Text PDF

Hypertension is the most common medical disorder encountered during pregnancy, occurring in about 6-8 % of pregnancies. Preeclampsia is a pregnancy-specific disorder that occurs after 20 weeks' gestation, characterized by hypertension and proteinuria. Preeclampsia can also occur superimposed upon chronic hypertension.

View Article and Find Full Text PDF

Genetic factors have been implicated in the pathogenesis of certain cases of MPGN. Familial cases of all three histological subtypes have been described. Genetic defects in the control of complement pathways appear to be at the root of many hereditary forms of MPGN.

View Article and Find Full Text PDF